VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TBPH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TBPHTheravance Biopharma, Inc.
$17.06$879M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTBPHQuarterly Financials

Theravance Biopharma, Inc. (TBPH) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Theravance Biopharma, Inc. (TBPH) quarterly income statement — complete revenue, gross profit & net income history

TBPH Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue17.7M45.89M19.99M26.2M15.39M18.75M16.87M14.26M14.5M17.57M15.69M13.75M10.42M14.65M12.45M11.05M13.2M14.95M13.19M12.91M
Revenue Growth %15.02%144.7%18.51%83.75%6.1%6.77%7.49%3.69%39.22%19.91%26.04%24.43%-21.06%-1.99%-5.63%-14.43%-7.44%-20.2%-27.73%-13.95%
Cost of Goods Sold1.44M1.51M8.11M10.49M11.45M09.27M9.95M8.97M8.31M1.34M9.43M14.57M15.35M9.87M14.92M23.25M31.23M43.74M51.09M
COGS % of Revenue8.12%3.28%40.58%40.05%74.42%-54.94%69.82%61.84%47.33%8.53%68.55%139.89%104.77%79.25%135.06%176.21%208.93%331.51%395.64%
Gross Profit16.26M44.38M11.88M15.71M3.94M18.75M7.6M4.3M5.54M9.25M14.35M4.32M-4.16M-699K2.58M-3.87M-10.06M-16.28M-30.55M-38.18M
Gross Margin %91.88%96.72%59.42%59.95%25.58%100%45.06%30.18%38.16%52.67%91.47%31.45%-39.89%-4.77%20.75%-35.06%-76.21%-108.93%-231.51%-295.64%
Gross Profit Growth %313.16%136.67%56.29%265.06%-28.89%102.7%-47.05%-0.51%233.21%1423.61%455.5%211.62%58.69%95.71%108.46%89.85%81.15%64.94%-267.31%-354.39%
Operating Expenses24.56M26.82M18.33M18.43M18.37M27.95M18.44M20.01M16.74M15.49M23.11M20.45M20.76M16.73M16.79M19.23M27.17M39.89M23.07M25.93M
OpEx % of Revenue138.76%58.44%91.71%70.36%119.38%149.06%109.3%140.34%115.44%88.2%147.29%148.72%199.26%114.22%134.82%174%205.87%266.87%174.85%200.8%
Selling, General & Admin17.72M19.86M00018.5M00015.85M15.23M19.28M19.18M16.73M16.28M16.22M17.84M21.52M21.3M25.93M
SG&A % of Revenue100.12%43.27%---98.65%---90.23%97.08%140.21%184.15%114.22%130.73%146.81%135.21%143.96%161.43%200.8%
Research & Development5.83M6.96M8.11M10.49M11.45M9.45M9.27M9.95M8.97M8.99M7.88M11.37M16.32M17.29M11.52M16.47M24.79M33.13M47.04M52.35M
R&D % of Revenue32.93%15.17%40.58%40.05%74.42%50.41%54.94%69.82%61.84%51.21%50.21%82.71%156.72%118.06%92.55%149.02%187.85%221.66%356.53%405.4%
Other Operating Expenses1000K01000K1000K1000K01000K1000K1000K-1000K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-8.3M17.57M-6.46M-2.73M-14.43M-9.2M-10.84M-15.71M-11.21M-6.24M-8.76M-16.12M-24.91M-17.43M-14.2M-23.1M-37.22M-56.17M-53.62M-64.11M
Operating Margin %-46.88%38.28%-32.29%-10.4%-93.8%-49.06%-64.25%-110.16%-77.27%-35.53%-55.82%-117.27%-239.15%-118.99%-114.06%-209.06%-282.08%-375.8%-406.36%-496.44%
Operating Income Growth %42.52%290.92%40.44%82.65%-28.79%-47.44%-23.71%2.59%55.01%64.2%38.32%30.21%33.07%68.97%73.51%63.97%55.63%26.57%30.02%11.18%
EBITDA-6.86M19.07M-6.05M-2.32M-14.02M-8.51M-10.41M-15.28M-10.78M-5.85M-7.42M-14.89M-24.15M-17.11M-13.4M-22.16M-36.24M-55.91M-52.01M-62.7M
EBITDA Margin %-38.76%41.56%-30.25%-8.84%-91.12%-45.35%-61.7%-107.17%-74.3%-33.29%-47.29%-108.32%-231.86%-116.81%-107.66%-200.59%-274.64%-374.11%-394.21%-485.54%
EBITDA Growth %51.07%324.23%41.91%84.84%-30.13%-45.43%-40.25%-2.59%55.39%65.82%44.64%32.81%33.35%69.4%74.23%64.65%55.99%25.59%30.31%10.32%
D&A (Non-Cash Add-back)1.44M1.51M409K409K413K695K429K427K432K392K1.34M1.23M758.75K320K797K936K982K252K1.6M1.41M
EBIT-8.3M17.57M-2.32M-2.73M-14.43M-8.3M-9.28M-12.75M-11.21M-6.6M-6.97M-14.95M-23.34M-17.43M-13.69M-20.1M-27.9M-37.8M-51.84M-64.11M
Net Interest Income0-583K-573K794K296K261K785K484K805K1.22M1.18M1.94M2.43M-551K1.21M303K-2.14M-11.32M-2.14M-10.44M
Interest Income0001.46M939K904K1.42M1.13M1.43M1.85M1.79M2.5M2.98M02.76M2.44M0338K01.17M
Interest Expense0583K573K663K643K643K630K644K629K623K609K568K550K551K1.54M2.14M2.14M11.66M2.14M11.61M
Other Income/Expense1.83M55.5M3.57M75.93M296K261K785K484K805K1.22M1.18M1.94M3.22M3.18M-1.31M313K-2.51M-1.5M-2.29M11.92M
Pretax Income-6.47M73.07M-2.89M73.21M-14.14M-8.94M-10.05M-15.22M-10.4M-5.02M-7.58M-14.19M-21.69M-14.25M-15.52M-22.79M-39.73M-57.66M-55.9M-52.19M
Pretax Margin %-36.56%159.22%-14.45%279.47%-91.88%-47.66%-59.59%-106.77%-71.72%-28.56%-48.32%-103.19%-208.25%-97.3%-124.62%-206.23%-301.11%-385.82%-423.7%-404.1%
Income Tax-1.54M12.04M-6.5M18.37M-559K6.59M2.65M1.31M1.26M3.49M1.37M1.46M395K3K507K5K524K151K7K220K
Effective Tax Rate %23.76%16.48%225.13%25.09%3.95%-73.7%-26.32%-8.59%-12.13%-69.66%-18.03%-10.28%-1.82%-0.02%-3.27%-0.02%-1.32%-0.26%-0.01%-0.42%
Net Income-4.93M61.02M3.62M54.84M-13.58M-15.53M-12.7M-16.53M-11.66M-8.51M-8.95M-15.64M-22.09M-10.36M916.63M-8.19M-25.95M-32.03M-35.31M-52.41M
Net Margin %-27.87%132.98%18.08%209.33%-88.24%-82.79%-75.28%-115.94%-80.42%-48.45%-57.03%-113.79%-212.04%-70.74%7361.91%-74.13%-196.62%-214.33%-267.61%-405.8%
Net Income Growth %63.67%493.02%128.47%431.75%-16.42%-82.46%-41.88%-5.65%47.19%17.87%-100.98%-91%14.87%67.65%2696.1%84.37%67.44%45.18%52.06%16.67%
Net Income (Continuing)-4.93M61.02M3.62M54.84M-13.58M-15.53M-12.7M-16.53M-11.66M-8.51M-8.95M-15.64M-22.09M-14.26M-16.02M-22.79M-40.26M-57.81M-55.91M-52.41M
Discontinued Operations00000000000001000K1000K1000K1000K1000K1000K0
Minority Interest00000000000000000000
EPS (Diluted)-0.101.150.071.08-0.27-0.31-0.26-0.34-0.24-0.17-0.17-0.28-0.35-0.2112.14-0.11-0.34-0.43-0.48-0.80
EPS Growth %64.37%470.97%126.92%417.65%-12.5%-82.35%-52.94%-21.43%31.43%19.05%-101.4%-154.55%-2.94%51.16%2629.17%86.25%72.58%53.26%58.62%20%
EPS (Basic)-0.101.200.071.09-0.27-0.31-0.26-0.34-0.24-0.17-0.17-0.28-0.35-0.2112.14-0.11-0.34-0.44-0.48-0.80
Diluted Shares Outstanding51.28M53.05M51.91M50.73M49.71M49.31M49.04M48.75M48.28M49.41M52.36M56.68M62.93M67.39M75.52M76.27M75.25M73.96M73.57M65.67M
Basic Shares Outstanding51.28M50.87M50.52M50.18M49.71M49.31M49.04M48.75M48.28M49.41M52.36M56.68M62.93M67.39M75.52M76.27M75.25M73.62M73.57M65.67M
Dividend Payout Ratio--------------------